Delivery Order SPE2DB20D2104-SPE2DB25FMXGC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,747.38 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ebglyss 250 mg/2 ml pen (2 ml). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this award...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.93 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ebyglss 250 mg/2 ml pen (2 ml). This firm fixed-price, competitively awarded contract involves a non-set-aside procurement and is scheduled for completion by July 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,700.74 to AmerisourceBergen Drug Corp for EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product for federal medical supply needs. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at approximately $2,977 to AmerisourceBergen Drug Corp for Ebygloss 250 mg/2 mL pen medication on August 4, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is structured as a child contract under a larger vehicle, leveraging the company's existing federal procurement relationship to supply...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ebyglss 250 mg/2 mL pen (2 mL) with a ceiling value of $4,121.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,534.57, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $25,885.03 to AmerisourceBergen Drug Corp for Ebylass 250 mg/2 ml pen (2 ml), a pharmaceutical product for federal medical procurement. The contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,011.30 contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML pharmaceutical products. The order is not set aside and is part of AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, EBGLYSS 250 MG/2 ML PEN 2ML, with a firm fixed price of $1,819.44 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $11,707.63, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025, and is a Firm Fixed Price Delivery Order. The award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXGCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,860.57 to AmerisourceBergen Drug Corp for Ebglyss 250 mg/2 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/4/25 |